Dermal grafting can be used as a natural, permanent and inexpensive filler in the management of facial scars such as acne, varicella and linear scars of varied aetiology, suggests a recent study.
New drug applications approved by US FDA as of 1 - 15 February 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Atopic dermatitis (AD) during infancy is associated with an increased risk of developing tooth decay by age three, according to results from the GUSTO* study.
Findings of two studies presented recently at the European Cancer Congress 2017 (ECCO 2017) demonstrates the effect of the PD-1 inhibitor, pembrolizumab, against a rare form of melanoma and bladder cancer.
Adult patients with atopic dermatitis (AD), particularly those who smoke, are vulnerable to autoimmune diseases, a recent study has found.
Radiologic imaging of high-stage cutaneous squamous cell carcinoma (CSCC) may influence management and positively affect outcomes, a recent study has found.
The presence of pressure area-related pain appears to be an independent predictor of developing category ≥2 pressure ulcer in high-risk hospital and community patients with acute illness, according to a study.
Skin cancer screening appears to offer benefits based on large ecological studies, a cohort study, a case-control study and a survey, but the evidence level of these reports is very low.
Use of pressure therapy may be beneficial in the management of hypertrophic scars (HS) from burn injuries, producing improvements in global scar score, pigmentation and redness, according to the results of a meta-analysis.
The likelihood of developing atopic dermatitis and food sensitization may be low among children with habitual consumption of yogurt products in infancy, according to a recent study.